Myocardial Perfusion Abnormalities in Young and Premenopausal Women with Systemic Lupus Erythematosus, Detected with 99MTC MIBI Myocardial Perfusion Scintigraphy – Prevalence and Correlation with Proatherogenic Factors

1. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of SLE. Am J Med 1976; 60: 221–5.10.1016/0002-9343(76)90431-9Search in Google Scholar

2. Manzi S, Meilahn E.N, Raairie J.E. et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiology 1997; 145(5): 408–415.10.1093/oxfordjournals.aje.a009122Search in Google Scholar

3. Gladman DD,Urowitz MB:Mortality in systemic lupus erythematosus. J Rheumatool Suppl 1987, 14(Suppl 13): 223–225.Search in Google Scholar

4. Petri M, Perez_Gutthann S, Spence D, Hochberg MC:Risk factor for coronary artery disease in patients with systemic lupus erythemtosus. Am J Med 1992, 93: 513–519.10.1016/0002-9343(92)90578-YOpen DOISearch in Google Scholar

5. Esdaile ЈM, Abrahamowitz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis and Rheumatism 2001; 44(10): 2331–2337.10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-ISearch in Google Scholar

6. Doria A, Iaccarino L, Ghirardello A, Zampieri S, Aarienti S, Sarzi-Puttini P, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006; 119: 700–6.10.1016/j.amjmed.2005.11.034Search in Google Scholar

7. Teixeira V and Tam Lai-Shan.N ovel Insights in Systemic Lupus Erythematosus and Atherosclerosis. January 2018 | Volume 4 | Article 262, Frontiers in Medicine | www.frontiersin.org.10.3389/fmed.2017.00262Search in Google Scholar

8. Fadda S, Nassar H, Gamal SM, Al-azizi H: Sub-clinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indices.Z Rheumatol. 2015 Aug; 74(6): 529–32. doi: 10.1007/s00393-014-1473-1.10.1007/s00393-014-1473-1Search in Google Scholar

9. Manzi S, Selzer F, Sutton –Tyrelli K et al. Prevalence and risk factors of carotid plaque in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 51–60.10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-DSearch in Google Scholar

10. Nermeen Khairy, Yasser Ezzat, Nahla Naeem, Radwa Taha, Rasha Wesam.Atherosclerosis bio-markers in female systemic lupus erythematosus patients with and without cardiovascular diseases. The Egyptian Rheumatologist (2017) 39, 7–12.10.1016/j.ejr.2016.03.003Search in Google Scholar

11. Sharma SK, Rathi M, Sahoo S, Prakash M, Dhir V, Singh S. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis. Lupus (2016) 25(5): 525–31. doi:10.1177/0961203315622822.10.1177/0961203315622822Open DOISearch in Google Scholar

12. Meroni P, Raschi E, Testoni C, Borghi M. Endothelial cell activation by antiphospholipid antibodies. Clin Immunol (2004) 112(2): 169–74. doi:10.1016/j.clim.2004.02.015.10.1016/j.clim.2004.02.01515240160Open DOISearch in Google Scholar

13. Sallai KK, Nagy E, Bodó I, Mohl A, Gergely P. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors. Scand J Rheumatol (2007) 36(3): 198–205. doi:10.1080/03009740601089283.10.1080/0300974060108928317657674Open DOISearch in Google Scholar

14. Roman MJ, Shanker B, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349(2): 399–406.10.1056/NEJMoa03547114681505Search in Google Scholar

15. Plazak W, Gryga K, Dziedzic H, Tomkiewicz-Pajak L, Konieczynska M, Podolec P, Musial J. Influence of atorvastatin on coronary calcifications and Myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, doubled-masked, placebo-controlled study. Arthritis Research & Therapy 2011,13: R117.10.1186/ar3402323935521774822Open DOISearch in Google Scholar

16. Boucelma M, Tahmi M, Chaudet H, Drahmoune R,Bouyoucef SE,Berrah A.Assessment of myocardial perfusion in systemic lupus erythematosus. La Revue de Médecine Interne 30(2):119-24 • October 2008 DOI: 10.1016/j.revmed.2008.06.022.10.1016/j.revmed.2008.06.02218818002Open DOISearch in Google Scholar

17. Zakavi SR, Joukar MH, Dabagh Kakhi VR, Khazael Gh, Ariana K. Prognostic evaluation of myocardial perfusion scintigraphy in patients with systemic lupus erythematosus admitted in the hospital for noncardiac problems. Iranian Journal of Nuclear medicine 2006; 14(suppl): 14–15.Search in Google Scholar

18. Sella E.M, Saato E.I. and Barbieri A.. Coronary Artery Angiography in Systemic Lupus Erythematosus Patients With Abnormal Myocardial Perfusion Scintigraphy. Arthritis & Rheumatism 2003; 48 (11): 3168–3175.10.1002/art.1126014613279Search in Google Scholar

19. Czzuszynska Z, Romanowwicz G. Myocardial perfusion in women with systemic lupus erythematosus and no symptoms of coronary artery disease. Nucl Med Rev Cbet East Eur 2004; 7(2): 171–174.Search in Google Scholar

20. Sun S.-S, Shiau Y.-C, Tsai S.-C, Lin C.-C, Kao A, and Lee C.-C. The role off 99mTc-sestamibi myocardial perfusion single-photon emission computed tomography (SPECT) in the detection of cardiovascular involvement in systemic lupus erythematosus with nonspecific chest complaints. Rheumatology 2011; 400: 1106–1111.10.1093/rheumatology/40.10.1106Search in Google Scholar

21. Nikpour M, Gladman D, Ibafiez D, Bruce IN, Burns R, Urowitz. Myocardial perfusion imaging in assessing risk of coronary events in patients with systemic lupus erythematosus. J Rheumatol, 2009; 36(2)(2): 288–294.10.3899/jrheum.08077619208561Open DOISearch in Google Scholar

22. Baharfard N, Shiroodi MK, Fotoohi F,Samangooie Sh,Asli N,Eghyesadi0Araghi P, Javadi H,Semnani Sh,Amini A,Assadi M:Myocardial perfusion imaging using a technetium-99m Sestamibi in asymptomatic and low risk for coronary artery disease patients with diagnosed systemic lupus erythematosus. Perfusion 2010, 26(2), 151–157.10.1177/026765911038984421078771Search in Google Scholar

23. Delcour KS, Khaja A, Chockalingam A, Kuppuswamy S, Dresser T.Outcomes in patients with abnormal myocardial perfusion imaging and normal coronary angiograms. Angiology 2009 Jun-Jul; 60(3): 318–321.10.1177/000331970831993818796451Open DOISearch in Google Scholar

24. Alqaisi F,Albadrin F,Jaffery Z,et al.Prognostic predictors and outcomes in patients with abnormal myocardial perfusion imaging and angiographically insignificant coronary artery disease. J Nucl Cardiol 2008 Nov-Dec; 15(6): 758–761.10.1007/BF0300735618984450Search in Google Scholar

25. Othman KMS and Assaf NY. Early detection of premature subclinical coronary atherosclerosis I systemic lupus erythematosus. The Egyptian Heart Journal (2013) 65, 281–288.10.1016/j.ehj.2012.12.003Search in Google Scholar

26. Ishimori MI, Martin R, Berman DS et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. J Am Coll Cardiol Img 2011; 4: 27–33.10.1016/j.jcmg.2010.09.01921232700Search in Google Scholar